Articles from Biotech Business (July 1, 2000)

Title	Author	Type	Words
GENENTECH REPORTS POSITIVE PHASE II RESULTS FOR ANTI-VEGF.		Statistical Data Included	1185
IDEC REPORTS FAVORABLE RESULTS OF FOUR ZEVALIN STUDIES.		Statistical Data Included	962
MAXIM PHARMACEUTICALS SELLS VACCINE TECHNOLOGY.		Brief Article	322
ORTEC COMPLETES PATIENT ENROLLMENT IN DONOR SITE STUDY.		Brief Article	308
PARADIGM MEDICAL RENEWS ALLIANCE WITH PHARMACIA.		Brief Article	242